Clive House 7 Plassey Park Road, Castletroy, County Limerick

Welcome to Clive House, a leading establishment and point of interest located at Castletroy, Plassey Park Road, 7. At Clive House, we offer comprehensive solutions that cover the entire lifecycle of product development and commercialization. Whether you require small local trials or large global programs, our services can be tailored to meet your specific needs.

Our end-to-end services, operational model, and cutting-edge technology enable us to deliver customized solutions that optimize real-world data, driving effective outcomes and achieving regulatory authorization. With our extensive experience in a broad range of therapeutic areas, we have successfully managed studies in major geographies and established solid working relationships with the world's leading investigators.

ICON, as a renowned institution, provides a full range of clinical, consulting, and commercial services across various industry sectors. We have led the development of 18 vaccines, including the world's first approved vaccine for COVID-19, resulting in FDA/EMA approvals. Our therapeutic experts regularly contribute to industry publications and the creation of thought leadership content, ensuring that we stay at the forefront of advancements in the field.

In addition to our expertise in clinical research, we also provide analysis and key insights on the operational, regulatory, and economic challenges faced by BioPharma companies and Medical Devices manufacturers. Our practical advice and recommendations help our clients navigate these challenges effectively.

At ICON, our mission is to accelerate the development of drugs and devices that save lives and improve the quality of life. We are committed to making a positive impact on our people, environment, and community through our initiative, ICON CARES.

Our services extend to various areas, including assessing strategies for mitigating infectious diseases, staying updated on regulatory changes, providing procedural and regulatory know-how for China biotechs in the EU, and advancing the potential of CAR T-cell therapies through clinical advancements.

We offer innovative early clinical solutions that can advance your drug development strategy, as well as expertise in mission-critical pricing, market access, and reimbursement. Our patient-centric approach to trials, coupled with real-world, real-time data, helps transform recruitment and ensure better outcomes.

For biotech specific needs, we provide full-service outsourcing and flexible support, including due diligence and asset valuation. As the world's largest provider of FSP services, we are well-equipped to meet your requirements.

Stay informed and updated through our informative blogs, where we discuss topics such as revised guidance instructions related to the Medicare Price Negotiation program, a current list of drugs likely to be selected for negotiation, the new EMA guideline on computerized systems and electronic data in clinical trials, and best practices for a more patient-centric approach to trials.

We also delve into disease surveillance and reporting, highlighting their critical role in public health and vaccine development. Additionally, we share insights on the EU CTR and the Government of Canada's initiatives for rare disorders.

Choose Clive House for all your drug and device development needs. Experience our expertise, innovation, and commitment to improving lives.